Literature DB >> 12359859

Tamoxifen may be an effective adjuvant treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.

William D Foulkes, John Goffin, Jean-Sébastien Brunet, Louis R Bégin, Nora Wong, Pierre O Chappuis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359859     DOI: 10.1093/jnci/94.19.1504-a

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics.

Authors:  Wendy S Rubinstein
Journal:  Fam Cancer       Date:  2007-07-12       Impact factor: 2.375

2.  Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

Authors:  Noah D Kauff; Susan M Domchek; Tara M Friebel; Mark E Robson; Johanna Lee; Judy E Garber; Claudine Isaacs; D Gareth Evans; Henry Lynch; Rosalind A Eeles; Susan L Neuhausen; Mary B Daly; Ellen Matloff; Joanne L Blum; Paul Sabbatini; Richard R Barakat; Clifford Hudis; Larry Norton; Kenneth Offit; Timothy R Rebbeck
Journal:  J Clin Oncol       Date:  2008-02-11       Impact factor: 44.544

3.  Drug therapy for hereditary cancers.

Authors:  Evgeny N Imyanitov; Vladimir M Moiseyenko
Journal:  Hered Cancer Clin Pract       Date:  2011-08-06       Impact factor: 2.857

4.  Inhibition of AKT suppresses the initiation and progression of BRCA1-associated mammary tumors.

Authors:  Hye Jung Baek; Sun Eui Kim; Jong Kwang Kim; Dong Hoon Shin; Tae Hyun Kim; Kwang Gi Kim; Chu-Xia Deng; Sang Soo Kim
Journal:  Int J Biol Sci       Date:  2018-10-03       Impact factor: 6.580

5.  The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers.

Authors:  Sharon Galper Grossman
Journal:  Rambam Maimonides Med J       Date:  2015-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.